KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Carlisle Companies (CSL) Research & Development (2016 - 2025)

Historic Research & Development for Carlisle Companies (CSL) over the last 16 years, with Q4 2025 value amounting to $12.9 million.

  • Carlisle Companies' Research & Development rose 4659.09% to $12.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $47.1 million, marking a year-over-year increase of 3305.08%. This contributed to the annual value of $47.1 million for FY2025, which is 3305.08% up from last year.
  • Latest data reveals that Carlisle Companies reported Research & Development of $12.9 million as of Q4 2025, which was up 4659.09% from $12.4 million recorded in Q3 2025.
  • Carlisle Companies' Research & Development's 5-year high stood at $13.8 million during Q2 2021, with a 5-year trough of -$20.6 million in Q4 2021.
  • Its 5-year average for Research & Development is $8.0 million, with a median of $9.2 million in 2024.
  • Per our database at Business Quant, Carlisle Companies' Research & Development plummeted by 30000.0% in 2021 and then surged by 12330.1% in 2022.
  • Over the past 5 years, Carlisle Companies' Research & Development (Quarter) stood at -$20.6 million in 2021, then skyrocketed by 123.3% to $4.8 million in 2022, then soared by 66.67% to $8.0 million in 2023, then increased by 10.0% to $8.8 million in 2024, then surged by 46.59% to $12.9 million in 2025.
  • Its Research & Development stands at $12.9 million for Q4 2025, versus $12.4 million for Q3 2025 and $11.1 million for Q2 2025.